Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Imalux Corporation Engages Advisor to Explore Strategic Options

February 22, 2013 9:54 am | by Bio-Medicine.Org | News | Comments

NAPLES, Fla. , Feb. 22, 2013 /- Falls River Group LLC announces they have been engaged by Imalux Corporation, manufacturer of the FDA cleared, Niris 1300e imaging system, to pursue strategic relationships for the company in order to increase the widespread use of the system. A newly developed application...

TOPICS:

Greatbatch, Inc. to Participate in the 2013 RBC Capital Markets Healthcare Conference

February 22, 2013 9:45 am | by The Associated Press | News | Comments

FRISCO, Texas--(BUSINESS WIRE)--Feb 22, 2013--Greatbatch, Inc. (NYSE: GB) today announced that Thomas J. Hook, president and CEO, and Michael Dinkins, senior vice president and CFO, will participate in the 2013 RBC Capital Markets Healthcare Conference in New York, New York on Wednesday, February...

Biotronik Lands Euro Approval for MRI-Friendly Heart Implants

February 22, 2013 9:29 am | by Mass Device | News | Comments

German medical device maker Biotronik won European regulatory approval for its Ilesto 7 line of MRI-friendly heart implants. The Ilesto 7 line includes cardiac resynchronization therapy defibrillator and one of the world's smallest implantable cardioverter-defibrillators, according to Biotronik.

TOPICS:
Advertisement

Lab21 and IntegraGen Partner to Develop New Colorectal Cancer Diagnostic

February 22, 2013 5:09 am | by The Associated Press | News | Comments

CAMBRIDGE, England--(BUSINESS WIRE)--Feb 22, 2013--Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to...

TOPICS:

Blaze Bioscience Announces Completion of Series A Financing - Brings Total Investment to $9.8 Million

February 22, 2013 5:00 am | by The Associated Press | News | Comments

SEATTLE--(BUSINESS WIRE)--Feb 22, 2013--Blaze Bioscience, Inc., a biotechnology company dedicated to developing innovative products to improve the lives of cancer patients, today announced the completion of a Series A financing totaling $8.5 million and bringing the total funds raised since...

TOPICS:

Panagene Signs Off with Dako to Supply PNA Oligomer Component

February 22, 2013 3:01 am | by The Associated Press | News | Comments

DAEJEON, South Korea--(BUSINESS WIRE)--Feb 22, 2013--Panagene announced it has signed a supply agreement with Dako Denmark A/S to supply PNA oligomer key component for incorporation into Dako’s diagnostic or research products. Dako, an Agilent Technologies Company since June 2012, is a leading...

TOPICS:

Class I Medical Device Recall: DePuy Orthopaedics, Inc. - LPS Diaphyseal Sleeve

February 22, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

The LPS Diaphyseal Sleeve to Diaphyseal Sleeve Base taper connection may not be sufficient to accommodate potential physiologic loads that may be transferred to the junction during normal gait activities by some patients. This may result in fracture of...

TOPICS:

Distinguishing Medical Device Recalls from Product Enhancements and Associated Reporting Requirements - Draft Guidance for Industry and Food and Drug Administration Staff

February 22, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

Defects or performance failures of marketed medical devices can pose serious risks to public health. Recalls serve both to correct a defect in current and future devices and to notify users of potential risks and steps to minimize the impact of device...

TOPICS:
Advertisement

Molecule Helps Nanoparticles Sneak Past the Immune System

February 21, 2013 5:11 pm | by Massachusetts Institute of Technology | News | Comments

Researchers have given nanoparticles the ability to tell immune cells not to eat them, a development that could have broad implications for medicine.Taking a cue from nature, researchers have designed nanoparticles that can avoid being destroyed by the immune system by convincing immune cells that the particles are part of the body.

TOPICS:

US HIFU Announces Name Change To SonaCare Medical

February 21, 2013 5:04 pm | by The Associated Press | News | Comments

USHIFU, LLC (US HIFU), a global leader in minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today that it has changed the company's name to SonaCare Medical, LLC (SonaCare Medical). Effective immediately, US HIFU will function as SonaCare Medical and all...

Iowa Resident Brings Suit Against Stryker For Damages Caused By Recalled Hip Implant

February 21, 2013 5:01 pm | by The Associated Press | News | Comments

NEW YORK--(BUSINESS WIRE)--Feb 21, 2013--Wendy Fleishman and Lexi J. Hazam of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that Karla Krogman of West Des Moines, Iowa, filed a lawsuit against Stryker Orthopaedics charging that the company manufactured...

TOPICS:

Tornier Reports Fourth Quarter and Fiscal Year 2012 Results and Provides 2013 Outlook

February 21, 2013 4:05 pm | by The Associated Press | News | Comments

AMSTERDAM--(BUSINESS WIRE)--Feb 21, 2013--Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the fourth quarter and fiscal year ended December 30, 2012. Revenue for the...

TOPICS:

Tornier Names David H. Mowry President and Chief Executive Officer

February 21, 2013 4:05 pm | by The Associated Press | News | Comments

AMSTERDAM--(BUSINESS WIRE)--Feb 21, 2013--Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that its Board of Directors has appointed David H. Mowry as President and Chief Executive Officer,...

TOPICS:

Investors Yawn at Latest Citron Jab, Send Intuitive Surgical Shares Up

February 21, 2013 3:44 pm | by Mass Device | News | Comments

Investors, who sent shares of Intuitive Surgical down 10% the 1st time Citron Research issued a negative report on the medical device company, yawned today at a 3rd missive from the short seller. ISRG shares were up slightly as of about 3:30 p.m. today to $561.07 apiece, despite Citron's repeated assertion that the stock is headed for $300 per share.

NMMC Physicians Implant State's First Vagal Nerve Stimulator for Heart Failure

February 21, 2013 3:39 pm | by The Associated Press | News | Comments

Doctors at North Mississippi Medical Center recently implanted the state's first vagal nerve stimulator as part of a clinical research study to treat heart failure through nerve stimulation in the neck. According to cardiac electrophysiologist Karl Crossen, M.D., and neurosurgeon Louis...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading